Swertiamarin Supplementation Prevents Obesity-related Chronic Inflammation and Insulin Resistance in Mice Fed a High-fat Diet

Overview

Journal Adipocyte

Specialties Cell Biology
Endocrinology
Physiology

Date 2021 Apr 2

PMID 33794740

Citations 11

Authors

Liang Xu

Dandan Li

Yuqin Zhu

Suili Cai

Xue Liang

Ying Tang

Shengnan Jin

Chunming Ding

Affiliations

Soon will be listed here.

Abstract

Obesity is characterized by low-grade chronic inflammation, which underlies insulin resistance and non-alcoholic fatty liver disease (NAFLD). Swertiamarin is a secoiridoid glycoside that has been reported to ameliorate diabetes and NAFLD in animal models. However, the effects of swertiamarin on obesity-related inflammation and insulin resistance have not been fully elucidated. Thus, this study investigated the effects of swertiamarin on inflammation and insulin resistance in high-fat diet (HFD)-induced obese mice. C57BL/6 mice were fed a HFD or HFD containing swertiamarin for 8 weeks. Obesity-induced insulin resistance and inflammation were assessed in the epididymal white adipose tissue (eWAT) and livers of the mice. Swertiamarin attenuated HFD-induced weight gain, glucose intolerance, oxidative stress, and insulin resistance, and enhanced insulin signalling in mice. Compared to HFD-fed mice, the swertiamarin-treated mice exhibited increased lipolysis and reduced adipocyte hypertrophy and macrophage infiltration in eWAT. Moreover, swertiamarin alleviated HFD-mediated hepatic steatosis and inflammation by suppressing activation of the p38 MAPK and NF-κB pathways within the eWAT and liver of obese mice. In conclusion, supplementation with swertiamarin attenuated weight gain and hepatic steatosis, and alleviated obesity-associated inflammation and insulin resistance, in obese mice.

Citing Articles

Network pharmacology analysis and animal experiment validation of inflammation inhibition by Swertiamarin in treating Ulcerative colitis.

Jiafeng T, Lijuan W, Lan W, Yiqing Y, Shiyu Y, Tao Z Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40014128 DOI: 10.1007/s00210-025-03944-z.

Swertiamarin ameliorates cognitive dysfunction by improving hyperglycemia and neuroinflammation in type 2 diabetic rats activation of the PI3K/AKT/GSK3β signaling pathway.

Tan B, Liu L, Wu T, Yuan F, Wang C Cent Eur J Immunol. 2025; 49(4):425-435.

PMID: 39944258 PMC: 11811717. DOI: 10.5114/ceji.2024.145754.

Gut microbiota and metabolomics unveil the mechanisms of in ameliorating visceral fat and serum lipids in high-fat diet-induced obese mice.

Ji X, Yu H, Wang L, Bao X, Si T, Li X Front Pharmacol. 2024; 15:1418063.

PMID: 39559734 PMC: 11570273. DOI: 10.3389/fphar.2024.1418063.

A Review of Animal Models for Studying Bone Health in Type-2 Diabetes Mellitus (T2DM) and Obesity.

Norazman S, Mohd Zaffarin A, Shuid A, Hassan H, Soleiman I, Kuan W Int J Mol Sci. 2024; 25(17).

PMID: 39273348 PMC: 11394783. DOI: 10.3390/ijms25179399.

Pyroptosis in Diabetic Peripheral Neuropathy and its Therapeutic Regulation.

Al Mamun A, Shao C, Geng P, Wang S, Xiao J J Inflamm Res. 2024; 17:3839-3864.

PMID: 38895141 PMC: 11185259. DOI: 10.2147/JIR.S465203.

References

Zhuge F, Ni Y, Nagashimada M, Nagata N, Xu L, Mukaida N . DPP-4 Inhibition by Linagliptin Attenuates Obesity-Related Inflammation and Insulin Resistance by Regulating M1/M2 Macrophage Polarization. Diabetes. 2016; 65(10):2966-79. DOI: 10.2337/db16-0317. View

Wang J, He J . Swertiamarin decreases lipid accumulation dependent on 3-ketoacyl-coA thiolase. Biomed Pharmacother. 2019; 112:108668. DOI: 10.1016/j.biopha.2019.108668. View

Ota T, Gayet C, Ginsberg H . Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. J Clin Invest. 2007; 118(1):316-32. PMC: 2104481. DOI: 10.1172/JCI32752. View

Lumeng C, Bodzin J, Saltiel A . Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007; 117(1):175-84. PMC: 1716210. DOI: 10.1172/JCI29881. View

Lauterbach M, Wunderlich F . Macrophage function in obesity-induced inflammation and insulin resistance. Pflugers Arch. 2017; 469(3-4):385-396. PMC: 5362664. DOI: 10.1007/s00424-017-1955-5. View

Vasu V, Modi H, Thaikoottathil J, Gupta S . Hypolipidaemic and antioxidant effect of Enicostemma littorale Blume aqueous extract in cholesterol fed rats. J Ethnopharmacol. 2005; 101(1-3):277-82. DOI: 10.1016/j.jep.2005.05.007. View

Vaidya H, Goyal R, Cheema S . Anti-diabetic activity of swertiamarin is due to an active metabolite, gentianine, that upregulates PPAR-γ gene expression in 3T3-L1 cells. Phytother Res. 2012; 27(4):624-7. DOI: 10.1002/ptr.4763. View

Hammond R, Levine R . The economic impact of obesity in the United States. Diabetes Metab Syndr Obes. 2011; 3:285-95. PMC: 3047996. DOI: 10.2147/DMSOTT.S7384. View

Jaishree V, Badami S, Kumar M, Tamizhmani T . Antinociceptive activity of swertiamarin isolated from Enicostemma axillare. Phytomedicine. 2008; 16(2-3):227-32. DOI: 10.1016/j.phymed.2008.09.010. View

10.

Park H, Jung H, Park E, Kim J, Lee W, Bae Y . Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol. 2004; 173(6):3589-93. DOI: 10.4049/jimmunol.173.6.3589. View

11.

Xu L, Kitade H, Ni Y, Ota T . Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease. Biomolecules. 2015; 5(3):1563-79. PMC: 4598764. DOI: 10.3390/biom5031563. View

12.

Hotamisligil G, Shargill N, Spiegelman B . Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993; 259(5091):87-91. DOI: 10.1126/science.7678183. View

13.

Bashan N, Dorfman K, Tarnovscki T, Harman-Boehm I, Liberty I, Bluher M . Mitogen-activated protein kinases, inhibitory-kappaB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity. Endocrinology. 2007; 148(6):2955-62. DOI: 10.1210/en.2006-1369. View

14.

Arkan M, Hevener A, Greten F, Maeda S, Li Z, Long J . IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med. 2005; 11(2):191-8. DOI: 10.1038/nm1185. View

15.

Wu H, Ghosh S, Perrard X, Feng L, Garcia G, Perrard J . T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation. 2007; 115(8):1029-38. DOI: 10.1161/CIRCULATIONAHA.106.638379. View

16.

Saravanan S, Hairul Islam V, Prakash Babu N, Pandikumar P, Thirugnanasambantham K, Chellappandian M . Swertiamarin attenuates inflammation mediators via modulating NF-κB/I κB and JAK2/STAT3 transcription factors in adjuvant induced arthritis. Eur J Pharm Sci. 2014; 56:70-86. DOI: 10.1016/j.ejps.2014.02.005. View

17.

Ferre P, Foufelle F . Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab. 2010; 12 Suppl 2:83-92. DOI: 10.1111/j.1463-1326.2010.01275.x. View

18.

Saltiel A, Olefsky J . Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017; 127(1):1-4. PMC: 5199709. DOI: 10.1172/JCI92035. View

19.

Kraakman M, Murphy A, Jandeleit-Dahm K, Kammoun H . Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function?. Front Immunol. 2014; 5:470. PMC: 4176397. DOI: 10.3389/fimmu.2014.00470. View

20.

Kitade H, Sawamoto K, Nagashimada M, Inoue H, Yamamoto Y, Sai Y . CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status. Diabetes. 2012; 61(7):1680-90. PMC: 3379680. DOI: 10.2337/db11-1506. View